Literature DB >> 19483159

Alpha1-antitrypsin Pittsburgh in a family with bleeding tendency.

Baolai Hua1, Liankai Fan, Yan Liang, Yongqiang Zhao, Edward G D Tuddenham.   

Abstract

We describe a 16-year-old girl and her 41-year-old father who both had a bleeding tendency, dramatic prolongation of all standard clotting assays, undetectable levels of plasma protein C activity, and low or borderline levels of factors X, XI and XII. Plasma and serum electrophoresis revealed a minor peak following the main alpha(1) globulin peak, of which the proportion was increased. Platelet aggregation by thrombin (final concentration 1 U/mL) was absent in both patients, but this inhibition can be overcome by increasing the concentration of thrombin (4 U/mL). The molecular defect responsible for these coagulation abnormalities was identified by genomic sequencing. Both patients are heterozygous for alpha(1)-antitrypsin Met 358 to Arg (alpha(1)-antitrypsin Pittsburgh). Seven other members of this pedigree had normal coagulation tests and do not carry the same genetic mutation. This unique family with alpha1-antitrypsin Pittsburgh sheds some light on the study of this extremely rare mutation and its inheritance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483159      PMCID: PMC2688583          DOI: 10.3324/haematol.2008.004739

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

1.  Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.

Authors:  Marc L Filion; Varsha Bhakta; Laurie H Nguyen; Peter S Liaw; William P Sheffield
Journal:  Biochemistry       Date:  2004-11-23       Impact factor: 3.162

2.  Calcium-dependent KEX2-like protease found in hepatic secretory vesicles converts proalbumin to albumin.

Authors:  S O Brennan; R J Peach
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

3.  Intracellular processing of complement pro-C3 and proalbumin is inhibited by rat alpha 1-protease inhibitor variant (Met352----Arg) in transfected cells.

Authors:  Y Misumi; K Ohkubo; M Sohda; N Takami; K Oda; Y Ikehara
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

4.  Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant.

Authors:  G L Long; T Chandra; S L Woo; E W Davie; K Kurachi
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

5.  Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency.

Authors:  D Vidaud; J Emmerich; M Alhenc-Gelas; J Yvart; J N Fiessinger; M Aiach
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

6.  Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.

Authors:  M J Heeb; J H Griffin
Journal:  J Biol Chem       Date:  1988-08-25       Impact factor: 5.157

7.  Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance.

Authors:  J Emmerich; M Alhenc-Gelas; S Gandrille; C Guichet; J N Fiessinger; M Aiach
Journal:  J Lab Clin Med       Date:  1995-04

8.  Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease.

Authors:  J H Lewis; R M Iammarino; J A Spero; U Hasiba
Journal:  Blood       Date:  1978-01       Impact factor: 22.113

9.  Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.

Authors:  C F Scott; R W Carrell; C B Glaser; F Kueppers; J H Lewis; R W Colman
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

10.  Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder.

Authors:  M C Owen; S O Brennan; J H Lewis; R W Carrell
Journal:  N Engl J Med       Date:  1983-09-22       Impact factor: 176.079

View more
  8 in total

1.  Alpha1-antitrypsin and the maintenance of hemostatic balance.

Authors:  Joseph Emmerich
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

2.  The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.

Authors:  Irene Martínez-Martínez; José Navarro-Fernández; Sonia Aguila; Antonia Miñano; Nataliya Bohdan; María Eugenia De La Morena-Barrio; Adriana Ordóñez; Constantino Martínez; Vicente Vicente; Javier Corral
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

3.  Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism.

Authors:  Hudie Wei; Haiyan Cai; Jiawei Wu; Zhenquan Wei; Fei Zhang; Xin Huang; Lina Ma; Lingling Feng; Ruoxi Zhang; Yunjie Wang; Hermann Ragg; Ying Zheng; Aiwu Zhou
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

Review 4.  [α1-antitrypsin Pittsburg mutations: report of two cases in the same family].

Authors:  L J Cao; X Bai; Z Q Yu; W Zhang; J Su; Z Y Wang; C G Ruan
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

Review 5.  Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum.

Authors:  Susana Seixas; Patricia Isabel Marques
Journal:  Appl Clin Genet       Date:  2021-03-22

Review 6.  Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.

Authors:  Steven P Grover; Nigel Mackman
Journal:  Front Cardiovasc Med       Date:  2022-05-03

7.  Loss of Serpina1 in Mice Leads to Altered Gene Expression in Inflammatory and Metabolic Pathways.

Authors:  Sri Harsha Meghadri; Beatriz Martinez-Delgado; Lena Ostermann; Gema Gomez-Mariano; Sara Perez-Luz; Srinu Tumpara; Sabine Wrenger; David S DeLuca; Ulrich A Maus; Tobias Welte; Sabina Janciauskiene
Journal:  Int J Mol Sci       Date:  2022-09-09       Impact factor: 6.208

8.  Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition.

Authors:  Leigh Ann Roddick; Varsha Bhakta; William P Sheffield
Journal:  BMC Biochem       Date:  2013-11-11       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.